Serum Response Factor (SRF), as a transcription factor, promotes epithelial cell migration and invasion in prostate cancer, gastric cancer, cervical cancer, and hepatocellular carcinoma and is associated with poor prognosis [169, 170, 171]. Here, SRF is linked to prostate carcinoma.